List of bibliographic references
Number of relevant bibliographic references: 14.
| Ident. | Authors (with country if any) | Title |
|---|
| 000014 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000232 (2020) |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000244 (2020) |
Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine] | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. |
| 000292 (2020) |
Fei Yu [République populaire de Chine] ; Lanying Du [États-Unis] ; David M. Ojcius [États-Unis] ; Chungen Pan [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] | Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. |
| 000312 (2020) |
Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis] | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. |
| 000389 (2020) |
Lisa Rosenbaum | Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. |
| 000404 (2020) |
Jianhui Nie [République populaire de Chine] ; Qianqian Li [République populaire de Chine] ; Jiajing Wu [République populaire de Chine] ; Chenyan Zhao [République populaire de Chine] ; Huan Hao [République populaire de Chine] ; Huan Liu [République populaire de Chine] ; Li Zhang [République populaire de Chine] ; Lingling Nie [République populaire de Chine] ; Haiyang Qin [République populaire de Chine] ; Meng Wang [République populaire de Chine] ; Qiong Lu [République populaire de Chine] ; Xiaoyu Li [République populaire de Chine] ; Qiyu Sun [République populaire de Chine] ; Junkai Liu [République populaire de Chine] ; Changfa Fan [République populaire de Chine] ; Weijin Huang [République populaire de Chine] ; Miao Xu [République populaire de Chine] ; Youchun Wang [République populaire de Chine] | Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. |
| 000414 (2020) |
Naveen Vankadari [Australie] ; Jacqueline A. Wilce [Australie] | Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. |
| 000445 (2020) |
Yaseen M. Arabi [Arabie saoudite] ; Robert Fowler [Canada] ; Frederick G. Hayden [États-Unis] | Critical care management of adults with community-acquired severe respiratory viral infection |
| 000540 (2020) |
Wanbo Tai [États-Unis] ; Lei He [République populaire de Chine] ; Xiujuan Zhang [États-Unis] ; Jing Pu [États-Unis, République populaire de Chine] ; Denis Voronin [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] | Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine |
| 000585 (2020) |
Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande] | COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. |
| 000618 (2020) |
John R. Greenland ; Marilyn D. Michelow ; Linlin Wang ; Martin J. London | COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. |
| 000670 (2020) |
Bin Cao ; Yeming Wang ; Danning Wen ; Wen Liu ; Jingli Wang ; Guohui Fan ; Lianguo Ruan ; Bin Song ; Yanping Cai ; Ming Wei ; Xingwang Li ; Jiaan Xia ; Nanshan Chen ; Jie Xiang ; Ting Yu ; Tao Bai ; Xuelei Xie ; Li Zhang ; Caihong Li ; Ye Yuan ; Hua Chen ; Huadong Li ; Hanping Huang ; Shengjing Tu ; Fengyun Gong ; Ying Liu ; Yuan Wei ; Chongya Dong ; Fei Zhou ; Xiaoying Gu ; Jiuyang Xu ; Zhibo Liu ; Yi Zhang ; Hui Li ; Lianhan Shang ; Ke Wang ; Kunxia Li ; Xia Zhou ; Xuan Dong ; Zhaohui Qu ; Sixia Lu ; Xujuan Hu ; Shunan Ruan ; Shanshan Luo ; Jing Wu ; Lu Peng ; Fang Cheng ; Lihong Pan ; Jun Zou ; Chunmin Jia ; Juan Wang ; Xia Liu ; Shuzhen Wang ; Xudong Wu ; Qin Ge ; Jing He ; Haiyan Zhan ; Fang Qiu ; Li Guo ; Chaolin Huang ; Thomas Jaki ; Frederick G. Hayden ; Peter W. Horby ; Dingyu Zhang ; Chen Wang | A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. |
| 000807 (2004) |
Nilesh P. Teli [États-Unis] ; Michael P. Timko [États-Unis] | Recent developments in the use of transgenic plants for the production of human therapeutics and biopharmaceuticals |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i -k "therapeutics"
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i \
-Sk "therapeutics" \
| HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= new
|étape= Analysis
|type= indexItem
|index= AbsEn.i
|clé= therapeutics
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021 |  |
